Remedy Entertainment OyOMXHEX: REMEDY

Remuneration Report 2025 (remedy remuneration report 2025)

· Issued by Remedy Entertainment Oy

REMEDY ENTERTAINMENT PLC

REMUNERATION REPORT 2025



REMEDY

ENTERTAINMENT PLC:

REMUNERATION REPORT FOR THE FINANCIAL YEAR 2025

  1. Introduction

    This is Remedy Entertainment Plc's (the "Company") Remuneration Report, which includes information on the remuneration paid to the Company's Board of Directors and Chief Executive Officer (the "CEO") during the financial year 2025.

    This Remuneration Report will be presented to the Company's Annual General Meeting 2026, which will resolve on the approval of this Remuneration Report. The Annual General Meeting's resolution is an advisory decision.

    The remuneration paid to the Board of Directors and CEO, as presented in this Remuneration Report, is based on the Company's Remuneration Policy approved by the Board of Directors. The Company's Remuneration Policy aims to promote the achievement of the Company's strategic objectives and the

    creation of shareholder value as well as to improve the Company's competitiveness and long-term financial performance.

    The Company's Remuneration Policy and this Remuneration Report are available on the Company website at https://www.investors.remedygames.com/governance/remuneration/.

  2. Development of the Board's and CEO's Remuneration

    The tables below present how the remuneration of the Board of Directors and CEO has developed compared to the Company's employees' average salary and to the Company's financial performance in the five preceding financial years.

    Paid salaries and fees 2021-2025 The Company's financial performance 2021-2025 EUR 2025 2024 2023 2022 2021

    Chairman of the Board of Directors (salaries and fees paid for Board work)1)

    54,000

    54,000

    54,000

    -

    48,000

    Chairman of the Board of Directors (salaries and fees paid based on employment contract)2)

    76,973

    97,530

    101,040

    97,744

    101,040

    Member of the Board of Directors3)

    36,000

    36,000

    29,000

    20,000

    35,200

    CEO4)

    198,284

    210,240

    210,240

    282,740

    764,935

    Average salary of a Remedy employee5)

    64,158

    63,907

    63,822

    60,103

    67,862

    1) Fee paid for Chairman of the Board duties, in line with the Annual General Meeting's resolution.

    2) Chairman of the Board changed 22 October 2025. Markus Mäki, the Chairman until 21 October 2025, is employed by Remedy. Henri Österlund, the Chairman from 22 October 2025, is not employed by the company.

    3) Calculated by dividing the annual fees for Board work with the average number of Board members.

    4) The CEO changed on 22 October 2025. Until 21 October 2025, the CEO was Tero Virtala, and starting from 22 October 2025, Markus Mäki.

    5) Calculated by dividing the total sum of salaries and fees for the financial year (excluding the CEO and Board of Directors) by the average number of personnel during the financial year.

    EUR 2025 2024 2023 2022 2021

    Revenue

    59.5

    50.7

    33.9

    43.6

    44.7

    EBITDA1)

    11.3

    2.5

    -17.0

    1.9

    14.5

    Operating profit (EBIT)

    -14.9

    -4.3

    -28.7

    -0.6

    11.4

    1) Operating profit (EBIT) + depreciation and amortization

  3. Remuneration paid to the Board of Directors during financial year 2025 Board member Board remuneration paid in the financial year 2025 (EUR) Attendance (%) in board meetings in the financial year 2025

    The Company's Annual General Meeting, held on April 10, 2025, resolved that the members to be elected to the Board of Directors will be paid the following fees for their term of office:

    • The Chairman of the Board of Directors is paid EUR 4,500 per month.

      Henri Österlund2)

      39,484

      100%

      Possible travel expenses are reimbursed in accordance with the principles of the Finnish Tax Administration

      Total

      198,000

    • Other members are paid EUR 3,000 per month.

      Markus Mäki1) 50,516 100%

      Kaisa Salakka 36,000 100%

      Kai Tavakka 36,000 100%

      Sonja Ängeslevä 36,000 100%

      concerning tax-exempt travel expenses. The fees paid to Board members during the financial year 2025 were in line with the Annual General Meeting's resolution. The fees paid are presented in the following table:

      1) Chairman of the Board until 21 October 2025. Member of the Board from 22 October 2025.

      2) Chairman of the Board starting from 22 October 2025.

      Board members do not participate in the Company's share-based incentive schemes, and they were not granted Company shares as fees in the financial year 2025.

      In addition to Markus Mäki's duties in the Board of Directors, he also served as the company's Chief Product Officer and interim CEO during 2025. Tasks related to these roles are not the tasks of the Chairman of the Board, and salary that Markus Mäki received from these operative positions is not included in the Board remuneration presented in this Section. The compensation paid to Markus Mäki based on employment are instead presented in Section 6.

  4. Remuneration paid to the CEO during the financial year 2025

The Company's CEO's remuneration comprises a fixed salary as well as short and long-term incentive programs. In the financial year 2025, the total remuneration paid to the Company's CEO amounted to EUR 198,324. Out of this compensation, 100% was fixed salary. The table below presents the salaries and fees paid to the CEO in the financial year 2025.

Paid salaries and fees in 2025 (EUR)

Fixed salary1) paid to the CEO 198,3242)

Short-term incentive bonuses3) paid to the CEO -4)5)

Long-term incentive rewards6) paid to the CEO -7)8)

Paid salaries and fees total 198,324

1) The fixed salary comprises monthly basic salary including taxable benefits.

2) EUR 23,525 of the fixed salary was paid to the interim CEO Markus Mäki.

3) The CEO's short-term incentive is a cash-based bonus program based on which a potential bonus is paid to the CEO once a year.

4) No short-term incentive bonuses were paid to Tero Virtala in 2025.

5) In 2025, Markus Mäki did not participate in the Company's short-term incentive programs.

6) The Company's long-term incentive programs comprise option plans for the Company's key personnel, including the CEO. Options granted during the year have been measured at value defined by IFRS 2. For further information on the Company's option plans, see "5. Further information on the CEO's option rights".

7) No long-term incentive rewards were paid to Tero Virtala in 2025.

8) In 2025, Markus Mäki did not participate in the Company's long-term incentive programs.

In the financial year 2025, no supplementary pension benefits were paid to Tero Virtala or Markus Mäki.

Company analysis

Earlier from Remedy Entertainment Oy

All Remedy Entertainment Oy news releases